EARL CAMPAZZI, M.D.
General Practice Physician in PALM BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
EARL CAMPAZZI, M.D. filed 405 Medicare Part D claims in 2023 as a General Practice Physician in PALM BEACH, Florida, prescribing 73% generic.
- 405
- Part D claims, 2023
- 73%
- generic prescribing
- $222.96
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
EARL CAMPAZZI, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
405 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
EARL CAMPAZZI, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about EARL CAMPAZZI, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Florida
How General Practice Physician compares to other specialties among Florida providers
General Practice Physician share within Florida
General Practice Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — General Practice Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- General Practice Physician ABMS/AOA estimate
Est. board-certified rate (General Practice Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume General Practice Physician US NPIs
Specialty board-certified rate — General Practice Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
EARL CAMPAZZI, M.D. appears in the CMS NPPES registry as a General Practice Physician provider holding M.D. credentials at 251 ROYAL PALM WAY STE 100A, PALM BEACH, FL, 33480, with a listed phone of (561) 440-8879. NPI 1407940646 was issued on 10/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CAMPAZZI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 405 prescription claims written by this provider, covering 66 Medicare beneficiaries and totaling roughly $83K in drug spend, split 27% brand-name and 73% generic by claim count, with an opioid prescribing rate of 11.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
General Practice Physician is a mid-sized specialty nationwide, with 16,677 enrolled providers across 56 states and an average of 2,872 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1407940646 |
|---|---|
| Specialty | General Practice Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/03/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm EARL CAMPAZZI, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EARL CAMPAZZI, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$223
Largest payer
DePuy Synthes Sales Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to EARL CAMPAZZI, M.D.. To verify EARL CAMPAZZI, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
27% brand-name claims vs 73% generic, on 405 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 560
- Total Day Supply
- 14,876
- Brand vs Generic
- 27% brand / 73% generic
- Brand Drug Cost
- $75K
- Generic Drug Cost
- $7K
- Opioid Claims
- 45 (11.1% rate)
Patient Demographics
- Average Patient Age
- 78.1 years
- Avg HCC Risk Score
- 1.21
- Gender Split
- 58% female / 42% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What EARL CAMPAZZI, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Alprazolam
Alprazolam
53 claims
- Zolpidem Tartrate
Zolpidem Tartrate
35 claims
- Tramadol Hcl
Tramadol Hcl
27 claims
- Lorazepam
Lorazepam
22 claims
- Clonazepam 21
Clonazepam
21 claims
- Temazepam 17
Temazepam
17 claims
- Abilify Maintena 13
Abilify Maintena
13 claims
- Eszopiclone 13
Eszopiclone
13 claims
| Drug | Claims |
|---|---|
| Alprazolam | 53 |
| Zolpidem Tartrate | 35 |
| Tramadol Hcl | 27 |
| Lorazepam | 22 |
| Clonazepam | 21 |
| Temazepam | 17 |
| Abilify Maintena Aripiprazole | 13 |
| Eszopiclone | 13 |
| Finasteride | 12 |
| Humulin N Insulin Nph Human Isophane | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
General Practice Physician Overview
How EARL CAMPAZZI, M.D. fits within the General Practice Physician landscape nationally.
EARL CAMPAZZI, M.D.'s 405 claims are below the specialty average of 2,872.
Nearby General Practice Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as CAMPAZZI.
Compare General Practice Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is EARL CAMPAZZI, M.D.'s specialty? ▼
How much does EARL CAMPAZZI, M.D. prescribe under Medicare Part D? ▼
Where is EARL CAMPAZZI, M.D. located? ▼
What is EARL CAMPAZZI, M.D.'s NPI number? ▼
Does EARL CAMPAZZI, M.D. prescribe more brand-name or generic drugs? ▼
Does EARL CAMPAZZI, M.D. prescribe opioids? ▼
How many General Practice Physician providers are there in the US? ▼
What drugs does EARL CAMPAZZI, M.D. prescribe most often? ▼
Does EARL CAMPAZZI, M.D. accept Medicare? ▼
How can I verify EARL CAMPAZZI, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology